Rios Garcia, M. ; Meissburger, B.* ; Chan, J. ; de Guia, R.M.* ; Mattijssen, F. ; Roessler, S.* ; Birkenfeld, A.L. ; Raschzok, N.* ; Riols, F. ; Tokarz, J. ; Giroud, M. ; Gil Lozano, M. ; Hartleben, G. ; Nawroth, P.P. ; Haid, M. ; López, M.* ; Herzig, S. ; Berriel Diaz, M.
Trip13 depletion in liver cancer induces a lipogenic response contributing to plin2-dependent mitotic cell death.
Adv. Sci. 9:e2104291 (2022)
Aberrant energy metabolism and cell cycle regulation both critically contribute to malignant cell growth and both processes represent targets for anticancer therapy. It is shown here that depletion of the AAA+-ATPase thyroid hormone receptor interacting protein 13 (Trip13) results in mitotic cell death through a combined mechanism linking lipid metabolism to aberrant mitosis. Diminished Trip13 levels in hepatocellular carcinoma cells result in insulin-receptor-/Akt-pathway-dependent accumulation of lipid droplets, which act as functional acentriolar microtubule organizing centers disturbing mitotic spindle polarity. Specifically, the lipid-droplet-coating protein perilipin 2 (Plin2) is required for multipolar spindle formation, induction of DNA damage, and mitotic cell death. Plin2 expression in different tumor cells confers susceptibility to cell death induced by Trip13 depletion as well as treatment with paclitaxel, a spindle-interfering drug commonly used against different cancers. Thus, assessment of Plin2 levels enables the stratification of tumor responsiveness to mitosis-targeting drugs, including clinically approved paclitaxel and Trip13 inhibitors currently under development.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Mtocs ; Plin2 ; Trip13 ; Hepatocellular Carcinoma ; Lipogenesis ; Mitosis ; Spindle Assembly Checkpoint
Keywords plus
Language
english
Publication Year
2022
Prepublished in Year
HGF-reported in Year
2022
ISSN (print) / ISBN
2198-3844
e-ISSN
2198-3844
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 9,
Issue: 29,
Pages: ,
Article Number: e2104291
Supplement: ,
Series
Publisher
Wiley
Publishing Place
Weinheim
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
90000 - German Center for Diabetes Research
30505 - New Technologies for Biomedical Discoveries
30201 - Metabolic Health
Research field(s)
Helmholtz Diabetes Center
Enabling and Novel Technologies
PSP Element(s)
G-501900-253
G-501900-251
G-501900-252
G-502400-001
A-630710-001
G-502594-001
Grants
Ministerio de Economía y Competitividad (MINECO) co-funded by FEDER Program of EU
Helmholtz Future Topic AMPro
Copyright
Erfassungsdatum
2022-10-24